Spectranetics Competitors and Similar CompaniesClear all
Spectranetics's competitors and similar companies include Boston Scientific and Cardiovascular Systems.
 Boston Scientific Boston Scientific is a company that develops, manufactures, and markets medical devices. |  Cardiovascular Systems Cardiovascular Systems, Inc. (CSI) is a medical technology company that develops solutions for the revascularization of patients with complex coronary and peripheral artery disease (PAD). | ||
Founding Date | Founding Date 1984 | Founding Date 1979 | Founding Date 1989 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Colorado Springs, US HQ Bagsværd, DK Suresnes, FR Leusden, NL | Locations Marlborough, US HQ Andar, BR Contagem, BR Ottawa, CA Shanghai, CN Coyol, CR La Aurora, CR see more | Locations Saint Paul, US HQ |
Employees | Employees 2746% decrease | Employees 53,00010% increase | Employees 7257% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 124.5 b | Valuation ($) 844 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $20.1b (FY, 2025) | Revenue (est.) $236.2m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods $6.2b (FY, 2025) | Cost of goods $63.4m (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit $13.9b (FY, 2025) | Gross profit $172.8m (FY, 2022) |
Net income | Net income N/A | Net income $2.9b (FY, 2025) | Net income ($36.9m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 2b | Total funding raised $ 69m |
For sources of this data, please see the company profile
View Company Profiles
Boston Scientific
HQ
Marlborough, US
Employees
53,000↑ 10% increase
Boston Scientific is a company that develops, manufactures, and markets medical devices.
View companyCardiovascular Systems
HQ
Saint Paul, US
Employees
725↓ 7% decrease
Cardiovascular Systems, Inc. (CSI) is a medical technology company that develops solutions for the revascularization of patients with complex coronary and peripheral artery disease (PAD).
View company